200 related articles for article (PubMed ID: 33907041)
1. P2X4 receptor participates in autophagy regulation in Parkinson's disease.
Zhang X; Wang J; Gao JZ; Zhang XN; Dou KX; Shi WD; Xie AM
Neural Regen Res; 2021 Dec; 16(12):2505-2511. PubMed ID: 33907041
[TBL] [Abstract][Full Text] [Related]
2. The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson's disease.
Wang J; Zhang XN; Fang JN; Hua FF; Han JY; Yuan ZQ; Xie AM
Neural Regen Res; 2022 Apr; 17(4):898-904. PubMed ID: 34472491
[TBL] [Abstract][Full Text] [Related]
3. P2X4-receptor participates in EAAT3 regulation via BDNF-TrkB signaling in a model of trigeminal allodynia.
Liu C; Zhang Y; Liu Q; Jiang L; Li M; Wang S; Long T; He W; Kong X; Qin G; Chen L; Zhang Y; Zhou J
Mol Pain; 2018; 14():1744806918795930. PubMed ID: 30146940
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rb1 protects dopaminergic neurons from inflammatory injury induced by intranigral lipopolysaccharide injection.
Li DW; Zhou FZ; Sun XC; Li SC; Yang JB; Sun HH; Wang AH
Neural Regen Res; 2019 Oct; 14(10):1814-1822. PubMed ID: 31169200
[TBL] [Abstract][Full Text] [Related]
5. P2X4R Overexpression Upregulates Interleukin-6 and Exacerbates 6-OHDA-Induced Dopaminergic Degeneration in a Rat Model of PD.
Ma J; Gao J; Niu M; Zhang X; Wang J; Xie A
Front Aging Neurosci; 2020; 12():580068. PubMed ID: 33328961
[TBL] [Abstract][Full Text] [Related]
6. P2X4 receptor in the dorsal horn partially contributes to brain-derived neurotrophic factor oversecretion and toll-like receptor-4 receptor activation associated with bone cancer pain.
Jin XH; Wang LN; Zuo JL; Yang JP; Liu SL
J Neurosci Res; 2014 Dec; 92(12):1690-702. PubMed ID: 24984884
[TBL] [Abstract][Full Text] [Related]
7. Extract of Polygala tenuifolia, Angelica tenuissima, and Dimocarpus longan Reduces Behavioral Defect and Enhances Autophagy in Experimental Models of Parkinson's Disease.
Li H; Kim J; Tran HNK; Lee CH; Hur J; Kim MC; Yang HO
Neuromolecular Med; 2021 Sep; 23(3):428-443. PubMed ID: 33432492
[TBL] [Abstract][Full Text] [Related]
8. P2X4 receptor in the dorsal horn contributes to BDNF/TrkB and AMPA receptor activation in the pathogenesis of remifentanil-induced postoperative hyperalgesia in rats.
Fu R; Li S; Li S; Gong X; Zhou G; Wang Y; Ding R; Zhu Z; Zhang L; Li Y
Neurosci Lett; 2021 Apr; 750():135773. PubMed ID: 33639220
[TBL] [Abstract][Full Text] [Related]
9. Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease.
Jin W
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31963575
[TBL] [Abstract][Full Text] [Related]
10. trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study.
Benisty S; Boissiere F; Faucheux B; Agid Y; Hirsch EC
Neuroscience; 1998 Oct; 86(3):813-26. PubMed ID: 9692719
[TBL] [Abstract][Full Text] [Related]
11. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
[TBL] [Abstract][Full Text] [Related]
12. Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways.
Zhang J; Niu N; Wang M; McNutt MA; Zhang D; Zhang B; Lu S; Liu Y; Liu Z
Int J Biochem Cell Biol; 2013 Aug; 45(8):1911-20. PubMed ID: 23791745
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
Porritt MJ; Batchelor PE; Howells DW
Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
[TBL] [Abstract][Full Text] [Related]
14. Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation.
Zhu H; Xiao F; Xiao Y; Guo Y; Shan X; Zhang Z; Zhang L; Guo H
J Neuroinflammation; 2023 Dec; 20(1):304. PubMed ID: 38110963
[TBL] [Abstract][Full Text] [Related]
15. Effect of stromal cell-derived factor-1/CXCR4 axis in neural stem cell transplantation for Parkinson's disease.
Xu JT; Qian Y; Wang W; Chen XX; Li Y; Li Y; Yang ZY; Song XB; Lu D; Deng XL
Neural Regen Res; 2020 Jan; 15(1):112-119. PubMed ID: 31535659
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM
Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192
[TBL] [Abstract][Full Text] [Related]
17. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
18. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation.
Jiang Z; Wang J; Sun G; Feng M
Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
[TBL] [Abstract][Full Text] [Related]
20. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
